Intensive care medicine
-
Intensive care medicine · Dec 2020
Randomized Controlled Trial Multicenter StudyNeurally adjusted ventilatory assist in acute respiratory failure: a randomized controlled trial.
We hypothesized that neurally adjusted ventilatory assist (NAVA) compared to conventional lung-protective mechanical ventilation (MV) decreases duration of MV and mortality in patients with acute respiratory failure (ARF). ⋯ NAVA decreased duration of MV although it did not improve survival in ventilated patients with ARF.
-
Intensive care medicine · Dec 2020
Multicenter Study Observational StudyClinical features, ventilatory management, and outcome of ARDS caused by COVID-19 are similar to other causes of ARDS.
The main characteristics of mechanically ventilated ARDS patients affected with COVID-19, and the adherence to lung-protective ventilation strategies are not well known. We describe characteristics and outcomes of confirmed ARDS in COVID-19 patients managed with invasive mechanical ventilation (MV). ⋯ In this large series, COVID-19 ARDS patients have features similar to other causes of ARDS, compliance with lung-protective ventilation was high, and the risk of 28-day mortality increased with the degree of ARDS severity.